Publication Name	World Journal of Clinical Oncology
Manuscript ID	95613
Country	Spain

Received	2024-04-14 10:02
Peer-Review Started	2024-04-14 10:02
To Make the First Decision
Return for Revision	2024-05-11 08:30
Revised	2024-05-22 06:49
Second Decision	2024-07-12 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-15 02:39
Articles in Press	2024-07-15 02:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-17 08:48
Publish the Manuscript Online	2024-08-16 08:03

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Current challenges in the treatment of gliomas: The molecular era
Manuscript Source	Invited Manuscript
All Author List	Castalia Fernández, Juan Zafra-Martín and Felipe Couñago
ORCID	Author(s) ORCID Number Castalia Fernández http://orcid.org/0000-0002-6005-3521 Juan Zafra-Martín http://orcid.org/0000-0003-4778-4271 Felipe Couñago http://orcid.org/0000-0001-7233-0234
Funding Agency and Grant Number
Corresponding Author	Castalia Fernández, MD, Staff Physician, Department of Radiation Oncology, GenesisCare Madrid, Emilio Vargas 16, Madrid 28043, Spain. castaliafer@gmail.com
Key Words	1p/19q-codeleted; Oligodendroglioma; Astrocytoma; Pediatric gliomas; Isocitrate dehydrogenase-type mutant; Radiotherapy; Chemotherapy; Gliomas
Core Tip	The current trimodal approach including surgery, radiotherapy, and chemotherapy for the treatment of gliomas has benefited from the introduction of molecular diagnosis. However, new challenges have appeared. There is still debate on the best therapeutic option. In this editorial, we focused on the controversial areas in molecular classification and new treatment advances.
Publish Date	2024-08-16 08:03
Citation	<p>Fernández C, Zafra-Martín J, Couñago F. Current challenges in the treatment of gliomas: The molecular era. <i>World J Clin Oncol</i> 2024; 15(8): 982-986</p>
URL	https://www.wjgnet.com/2218-4333/full/v15/i8/982.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i8.982

Full Article (PDF)	WJCO-15-982-with-cover.pdf
Manuscript File	95613_Auto_Edited_071319.docx
Answering Reviewers	95613-answering-reviewers.pdf
Audio Core Tip	95613-audio.m4a
Conflict-of-Interest Disclosure Form	95613-conflict-of-interest-statement.pdf
Copyright License Agreement	95613-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	95613-non-native-speakers.pdf
Peer-review Report	95613-peer-reviews.pdf
Scientific Misconduct Check	95613-scientific-misconduct-check.png
Scientific Editor Work List	95613-scientific-editor-work-list.pdf
CrossCheck Report	95613-crosscheck-report.png
CrossCheck Report	95613-crosscheck-report.pdf